Strategy
Portfolio
People
Careers
September 14, 2018
FDA Puts FibroGen’s Pamrevlumab on Fast Track as IPF Treatment
Back
Portfolio News
Next
Back
Blog
Next
News
Blog
Foresite Labs
Contact Us
Home
Strategy
Portfolio
People
Careers
News
Blog
Foresite Labs
Contact
Investor Login
Terms
Privacy Policy
©2022 Foresite Capital Management, LLC
Site by Goodlab